PC3I News
Four Penn Center for Cancer Care Innovation (PC3I) Faculty will be presenting the latest advances in blood cancer research and treatment at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition.
2261. Overall Survival of Adult Acute Lymphoblastic Leukemia (ALL) Patients By Facility Volume and Type: A National Cancer Database Report
Kaitlyn C Dykes, MD, BS, Jiling Chou, MA, Allison Taylor, MD, MS, MA Xiaoyang, and Catherine Lai, MD
Poster Session: December 10, 17:30
668. Advanced Practice Providers (APPs) in Hematology: Work Practices, Interactions with Physicians, and Opportunities for Collaboration within the American Society of Hematology (ASH)
Leah E Masselink, PhD, Clese E Erikson, MPAff, Gina Moses, Faith E. Davies, MD, Azam Farooqui, MD, Peter A. Kouides, MD, Srikanth Nagalla, MBBS, MS, and Ariela L. Marshall, MD
Oral Session: December 11, 16:45
426. Real World Effectiveness of “7 + 3” Intensive Chemotherapy Vs Venetoclax and Hypomethylating Agent for Initial Therapy in Adult Acute Myeloid Leukemia
Andrew Matthews, MD, Alexander E. Perl, MD, Selina M. Luger, MD, FRCPC, Saar Gill, MD, PhD, Catherine Lai, MD, David L. Porter, MD, Sarah Skuli, MD, PhD, Ximena Jordan Bruno, Craig W. Freyer, PharmD, Alison Carulli, PharmD, Martin P. Carroll, MD, Daria V. Babushok, MD, Noelle V. Frey, MD, MS, Elizabeth O. Hexner, MD, MSTR, Mary Ellen Martin, MD, Shannon R. McCurdy, MD, Edward A. Stadtmauer, MD, Alison W. Loren, MD, Vikram R Paralkar, MD, Ivan Maillard, MD, PhD, and Keith W. Pratz, MD
Oral Session: December 11, 10:45
983. CD22-Targeted CAR-Modified T-Cells Safely Induce Remissions in Children and Young Adults with Relapsed, CD19-Negative B-ALL after Treatment with CD19-Targeted CAR T-Cells
Regina M. Myers, MD, Amanda M. DiNofia, MD, MSCE, Yimei Li, PhD, Caroline Diorio, MD, Richard Aplenc, MD, PhD, Diane Baniewicz, MSN, CRNP, Jennifer L Brogdon, PhD, Colleen Callahan, MSN, CRNP, Boris Engels, PhD, Joseph A. Fraietta, PhD, Vanessa Gonzalez, MBA, Emma Iannone, BS, Allison Barz Leahy, MD, MSCE, Hongyan Liu, PhD, Susan E. McClory, MD, PhD, Susan R. Rheingold, MD, Laura Shinehouse, BA, Gerald Wertheim, MD, PhD, Lisa Wray, MD, Noelle V. Frey, MD, MS, Shannon L. Maude, MD, PhD, and Stephan A. Grupp, MD, PhD
Oral Session: December 12, 17:30
4942. Influence of Household Income on Health-Related Quality of Life in Children with Acute Myeloid Leukemia
Haley Newman, MD, Yimei Li, PhD, Yuan-Shung V. Huang, MS, Caitlin W Elgarten, MD, MSCE, Regina M. Myers, MD, Jenny Ruiz, MD, Allison Barz Leahy, MD, MSCE, Catherine Aftandilian, MD, Staci D. Arnold, MD, MBA, MPH, Kira O Bona, MD, MPH, Mallorie M. Heneghan, MD, M Monica Gramatges, MD, PhD, Kelly W Maloney, MD, Arunkumar J. Modi, MD, Rajen Mody, MD, MS, Naomi J Winick, MD, Elaine Morgan, MD, Jennifer J. Wilkes, MD, MSCE, Alix E. Seif, MD, Brian T. Fisher, Richard Aplenc, MD, PhD, and Kelly D. Getz
Poster Session: December 12, 18:00
898. Barriers to Transition from Pediatric to Adult Care in Adolescents and Young Adults with Sickle Cell Disease: A Mixed-Method Study on the Impact of Systems of Inequity
Kemar V. Prussien, PhD, Haley L. Faust, BA, Kim Smith-Whitley, MD1, Lamia P. Barakat, PhD, and Lisa A. Schwartz, PhD
Oral Session: December 12, 15:30
4862. Fried’s Frailty Phenotype Predicts Mortality and Survival for Newly Diagnosed Older Patients with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Cristian C. Taborda, MD, Shannon H Gier, BS, Avery W Stivale, BS, Alexander E. Perl, MD, Saar Gill, MD, PhD, Daria V. Babushok, MD, Elizabeth O. Hexner, MD, MSTR, Noelle V. Frey, MD, MS, Catherine Lai, MD, Ximena Jordan Bruno, Mary Ellen Martin, MD, Ivan Maillard, MD, PhD, David L. Porter, MD, Alison W. Loren, MD, Keith W. Pratz, MD, Selina M. Luger, MD, FRCPC, Phyllis A. Gimotty, PhD, and Shannon R. McCurdy, MD
Poster Session: December 12, 18:00
4954. Comparison of Patients with Newly Diagnosed (ND) Acute Myeloid Leukemia (AML) Treated with Venetoclax and Hypomethylating Agents Vs Other Therapies By TP53 and IDH1/2 Mutation: Results from the AML Real World Evidence (ARC) Initiative
Ofir Wolach, Jacqueline S. Garcia, MD, Pinkal Desai, MD, MPH, Pankit Vachhani, MD, Joshua F. Zeidner, MD, Sameem Abedin, MD, Kendra Sweet, MD, Catherine Lai, MD, Yakir Moshe, MD, PhD, Daniel A. Pollyea, MD, Marin Xavier, Boaz Nachmias, Tsila Zuckerman, MD, Sangmin Lee, Evan C. Chen, Srilakshmi Bathini, MD, Wesleigh Edwards, Cat N. Bui, PharmD, Wei-Han Cheng, PhD, Catherine Miller, PharmD, Annie Guerin, Jessica Maitland, Esprit Ma, MPH, Melissa Montez, PharmD, Moshe Grunspan, and Aaron D Goldberg, MD, PhD
Poster Session: December 12, 18:00
Additionally, PC3I Faculty will serve as moderators of the following sessions:
Moderator: Catherine Lai.
Implications of the Aging Microenvironment
Moderator: Catherine Lai.
Related News
PC3I News
PC3I and Tennessee Oncology’s McKay Institute for Oncology Transformation Unveil New Collaborative Relationship
02.06.2024
PC3I and Tennessee Oncology’s McKay Institute for Oncology Transformation announce an academic-community oncology innovation partnership to improve cancer care delivery.
PC3I News
PC3I Leadership Presents at 2023 AORTIC International Conference on Cancer in Africa
12.05.2023
PC3I Associate Director Surbhi Grover and Deputy Director Katharine Rendle presented research at the 14th AORTIC International Conference on Cancer in Africa, which took place in Dakar, Senegal.
PC3I News
2024 PC3I Innovation Accelerator Request for Proposals
11.10.2023
Through the Innovation Accelerator, the Penn Center for Cancer Care Innovation (PC3I) at the Abramson Cancer Center (ACC) invite applications for initiatives that aim to create and test innovative solutions to address challenges in productivity, efficiency, clinician wellbeing, or access in cancer care at Penn Medicine